[Drug-induced respiratory depression].
Nakadate
Toshihide
T
Department of Critical Care Medicine, Iwate Medical University School of Medicine.
D000701:Analgesics, Opioid / Q000009:adverse effects*; D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000378:metabolism / Q000633:toxicity; D000927:Anticonvulsants / Q000009:adverse effects*; D001463:Barbiturates / Q000009:adverse effects* / Q000493:pharmacokinetics; D001569:Benzodiazepines / Q000009:adverse effects* / Q000378:metabolism / Q000633:toxicity; D006801:Humans; D009020:Morphine / Q000009:adverse effects; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy
D000701:Analgesics, Opioid; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D001463:Barbiturates; D001569:Benzodiazepines; D009020:Morphine; C032232:barbituric acid